GlassScriptPhysician profile
Christopher J Walsh
NPI 1811966955
$20,594.73
in general payments reported to CMS, 2019-2025
47 companies · $4,154 in 2025
The $4,154 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,313 · 2020: $3,324 · 2021: $1,896 · 2022: $2,663 · 2023: $2,960 · 2024: $1,285 · 2025: $4,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,781 · Travel and Lodging: $1,267 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,780.98 |
| Travel and Lodging | $1,267.27 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $3,655.41 | 2019-2020 | |
| Teleflex LLC | $3,233.62 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $2,201.51 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, General - Erectile Dysfunction |
| Astellas Pharma US INC | $1,448.99 | 2019-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $1,255.41 | 2020-2025 | Aquabeam System, Aquabeam Robotic System |
| Medtronic USA, INC. | $1,123.45 | 2020 | |
| Medtronic, INC. | $847.91 | 2022-2025 | Altaviva |
| Coloplast Corp | $686.10 | 2019-2025 | Speedicath, Titan |
| Pfizer INC. | $603.83 | 2019-2025 | |
| Intuitive Surgical, INC. | $564.41 | 2021-2022 | |
| Antares Pharma, INC. | $484.50 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $388.22 | 2021-2024 | Erleada, Akeega, Balversa |
| Rochester Medical Corporation | $386.16 | 2021-2022 | |
| Axonics, INC. | $382.24 | 2021-2024 | Axonics |
| Calyxo, INC. | $362.78 | 2025 | Cvac Aspiration System |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $308.95 | 2019-2023 | Xiaflex, Aveed |
| Laborie Medical Technologies Corp. | $298.92 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $215.58 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $181.49 | 2023-2024 | Gemtesa |
| Bioprotect Medical, INC. | $175.03 | 2024-2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $171.79 | 2022-2025 | |
| Allergan, INC. | $157.22 | 2019-2022 | |
| Urogen Pharma, INC. | $137.07 | 2021-2023 | Jelmyto |
| Minze Health, INC | $135.76 | 2025 | Minze Homeflow |
| Stryker Corporation | $128.51 | 2024 | Infinity, Aim (Advanced Imaging Modality), 1788 |
| Astrazeneca Pharmaceuticals LP | $115.19 | 2023-2025 | Lynparza |
| Ferring Pharmaceuticals INC. | $102.68 | 2019 | |
| Urovant Sciences INC | $93.14 | 2021-2022 | |
| Palette Life Sciences, INC. | $80.92 | 2023 | |
| Valencia Technologies Corporation | $76.50 | 2025 | Ecoin Device Kit |
| Convatec INC. | $71.20 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $64.26 | 2021-2022 | |
| Olympus America INC. | $56.13 | 2022-2025 | Itind System |
| Blue Earth Diagnostics | $52.70 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $50.00 | 2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $44.52 | 2019-2020 | |
| Amgen INC. | $42.50 | 2019-2022 | |
| Halozyme INC | $39.81 | 2023 | |
| Zyla Life Sciences, INC. | $31.34 | 2019 | |
| 180 Medical, INC. | $29.74 | 2025 | Gentlecath |
| Foundation Medicine, INC. | $28.27 | 2021 | |
| Myovant Sciences INC. | $22.49 | 2021 | |
| Metuchen Pharmaceuticals | $18.14 | 2019 | |
| Therapeuticsmd, INC. | $15.35 | 2019 | |
| Clarus Therapeutics INC. | $13.95 | 2021 | |
| Travere Therapeutics, INC. | $11.04 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$27,130.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.